Pharma channel feed – Endpoints News

Pharma channel feed

Novartis sounds alarm on unsustainable drug supply chain if no-deal Brexit becomes reality

7 years ago

In another setback for Eli Lilly, FDA follows EMA in calling for a halt to new Lartruvo prescriptions

7 years ago

UK looks to ensure pharma submissions can continue under no deal Brexit

7 years ago

FDA opioid adcomm chair blasts agency for 'willful blindness that borders on the criminal'

7 years ago

Vertex sharpens focus on gene-editing in licensing deal with Merck KGaA

7 years ago

EMA wants docs to stop prescribing Eli Lilly’s cancer drug Lartruvo — and here's why

7 years ago

Microbiome test maker uBiome cuts 55 jobs to sharpen focus on drugs, partnerships — CNBC

7 years ago

With the FDA running out of funds, healthcare groups warn that the drug approval process will soon be derailed

7 years ago

FDA finalizes accelerated approval labeling guidance

7 years ago

TG Therapeutics' shares jump as umbralisib wins FDA's breakthrough status

7 years ago

FDA slaps a clinical hold on messenger RNA program for rare genetic disease

7 years ago

Celgene's top 20 upfront hits: Just how generous was Celgene in dealmaking? Let's review the records

7 years ago

Safety concerns lead to a split FDA panel vote on Sanofi/Lexicon diabetes drug

7 years ago

Celgene inks first deals since Bristol-Myers announced $74B buyout — bets $80M on immunometabolism

7 years ago

Scoop: Forma axes discovery biology team as part of a broader reorganization

7 years ago

With J&J deal to assess value of Apple watch in atrial fibrillation, tech giant fortifies its foray into healthcare

7 years ago

Looking to make a splash at JPMorgan, Eli Lilly rushed to put its $8B buyout deal together for Loxo in 10 days

7 years ago

FDA revises draft guidance on rare disease drug R&D

7 years ago

Dragonfly preps clinical takeoff, inking a collaboration pact with MD Anderson

7 years ago

Five Prime cuts 41 jobs, days before presenting data at ASCO meeting of GI cancers

7 years ago

Gottlieb, Marks detail plans to advance development of cell and gene therapies

7 years ago

In a first, China’s BeiGene scores FDA ‘breakthrough’ status for BTK inhibitor — potential rival for Imbruvica

7 years ago

Cummings triggers probe into pricing practices of dozen major drugmakers

7 years ago

Aimmune says US government shutdown stymied its peanut allergy drug application

7 years ago

First page Previous page 278 279 280281282 283 284 Next page Last page